These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
516 related articles for article (PubMed ID: 11160239)
1. The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response. Melby PC; Chandrasekar B; Zhao W; Coe JE J Immunol; 2001 Feb; 166(3):1912-20. PubMed ID: 11160239 [TBL] [Abstract][Full Text] [Related]
2. Progressive visceral leishmaniasis is driven by dominant parasite-induced STAT6 activation and STAT6-dependent host arginase 1 expression. Osorio EY; Zhao W; Espitia C; Saldarriaga O; Hawel L; Byus CV; Travi BL; Melby PC PLoS Pathog; 2012 Jan; 8(1):e1002417. PubMed ID: 22275864 [TBL] [Abstract][Full Text] [Related]
3. Transcriptional Profiling in Experimental Visceral Leishmaniasis Reveals a Broad Splenic Inflammatory Environment that Conditions Macrophages toward a Disease-Promoting Phenotype. Kong F; Saldarriaga OA; Spratt H; Osorio EY; Travi BL; Luxon BA; Melby PC PLoS Pathog; 2017 Jan; 13(1):e1006165. PubMed ID: 28141856 [TBL] [Abstract][Full Text] [Related]
4. Cloning of Syrian hamster (Mesocricetus auratus) cytokine cDNAs and analysis of cytokine mRNA expression in experimental visceral leishmaniasis. Melby PC; Tryon VV; Chandrasekar B; Freeman GL Infect Immun; 1998 May; 66(5):2135-42. PubMed ID: 9573100 [TBL] [Abstract][Full Text] [Related]
5. Infection pattern and immune response in the spleen and liver of BALB/c mice intracardially infected with Leishmania donovani amastigotes. Mukherjee P; Ghosh AK; Ghose AC Immunol Lett; 2003 Apr; 86(2):131-8. PubMed ID: 12644314 [TBL] [Abstract][Full Text] [Related]
6. Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani. Melby PC; Yang YZ; Cheng J; Zhao W Infect Immun; 1998 Jan; 66(1):18-27. PubMed ID: 9423834 [TBL] [Abstract][Full Text] [Related]
7. Splenic CD4+ T Cells in Progressive Visceral Leishmaniasis Show a Mixed Effector-Regulatory Phenotype and Impair Macrophage Effector Function through Inhibitory Receptor Expression. Medina-Colorado AA; Osorio EY; Saldarriaga OA; Travi BL; Kong F; Spratt H; Soong L; Melby PC PLoS One; 2017; 12(1):e0169496. PubMed ID: 28103263 [TBL] [Abstract][Full Text] [Related]
8. Reduced nitric oxide synthase 2 (NOS2) promoter activity in the Syrian hamster renders the animal functionally deficient in NOS2 activity and unable to control an intracellular pathogen. Perez LE; Chandrasekar B; Saldarriaga OA; Zhao W; Arteaga LT; Travi BL; Melby PC J Immunol; 2006 May; 176(9):5519-28. PubMed ID: 16622021 [TBL] [Abstract][Full Text] [Related]
9. Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: evidence for mixed Th1- and Th2-like responses in visceral leishmaniasis. Basu R; Bhaumik S; Basu JM; Naskar K; De T; Roy S J Immunol; 2005 Jun; 174(11):7160-71. PubMed ID: 15905560 [TBL] [Abstract][Full Text] [Related]
10. Elongation factor-2, a Th1 stimulatory protein of Leishmania donovani, generates strong IFN-γ and IL-12 response in cured Leishmania-infected patients/hamsters and protects hamsters against Leishmania challenge. Kushawaha PK; Gupta R; Sundar S; Sahasrabuddhe AA; Dube A J Immunol; 2011 Dec; 187(12):6417-27. PubMed ID: 22079980 [TBL] [Abstract][Full Text] [Related]
11. Transcriptional profiling of the spleen in progressive visceral leishmaniasis reveals mixed expression of type 1 and type 2 cytokine-responsive genes. Espitia CM; Saldarriaga OA; Travi BL; Osorio EY; Hernandez A; Band M; Patel MJ; Medina AA; Cappello M; Pekosz A; Melby PC BMC Immunol; 2014 Nov; 15():38. PubMed ID: 25424735 [TBL] [Abstract][Full Text] [Related]
12. Phlebotomus papatasi sand fly salivary gland lysate down-regulates a Th1, but up-regulates a Th2, response in mice infected with Leishmania major. Mbow ML; Bleyenberg JA; Hall LR; Titus RG J Immunol; 1998 Nov; 161(10):5571-7. PubMed ID: 9820534 [TBL] [Abstract][Full Text] [Related]
13. Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani. Engwerda CR; Murphy ML; Cotterell SE; Smelt SC; Kaye PM Eur J Immunol; 1998 Feb; 28(2):669-80. PubMed ID: 9521077 [TBL] [Abstract][Full Text] [Related]
14. Treatment of Leishmania donovani-infected hamsters with miltefosine: analysis of cytokine mRNA expression by real-time PCR, lymphoproliferation, nitrite production and antibody responses. Gupta R; Kushawaha PK; Samant M; Jaiswal AK; Baharia RK; Dube A J Antimicrob Chemother; 2012 Feb; 67(2):440-3. PubMed ID: 22121191 [TBL] [Abstract][Full Text] [Related]
15. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10. Bhaumik SK; Naskar K; De T Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771 [TBL] [Abstract][Full Text] [Related]
16. TLR-mediated distinct IFN-γ/IL-10 pattern induces protective immunity against murine visceral leishmaniasis. Paul J; Karmakar S; De T Eur J Immunol; 2012 Aug; 42(8):2087-99. PubMed ID: 22622993 [TBL] [Abstract][Full Text] [Related]